138 related articles for article (PubMed ID: 25782922)
1. The role of renin-angiotensin system in the chronic allograft nephropathy: an immunohistochemical study.
Viero RM; da Silva MG; dos Santos DC; de Carvalho MF; de Andrade LG
Ren Fail; 2015 Jun; 37(5):827-34. PubMed ID: 25782922
[TBL] [Abstract][Full Text] [Related]
2. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
[TBL] [Abstract][Full Text] [Related]
3. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
4. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system: an old, newly discovered player in immunoregulation.
Geara AS; Azzi J; Jurewicz M; Abdi R
Transplant Rev (Orlando); 2009 Jul; 23(3):151-8. PubMed ID: 19539879
[TBL] [Abstract][Full Text] [Related]
7. [The effects of blocking intrarenal renin-angiotensin system on the expression of transforming growth factor-beta1 mRNA and extracellular matrix components].
Zhou C; Li J; Wang H
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):44-6. PubMed ID: 11798627
[TBL] [Abstract][Full Text] [Related]
8. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis.
Gilbert RE; Wu LL; Kelly DJ; Cox A; Wilkinson-Berka JL; Johnston CI; Cooper ME
Am J Pathol; 1999 Aug; 155(2):429-40. PubMed ID: 10433936
[TBL] [Abstract][Full Text] [Related]
9. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
[TBL] [Abstract][Full Text] [Related]
11. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
12. Effect of all-trans retinoic acid treatment on prohibitin and renin-angiotensin-aldosterone system expression in hypoxia-induced renal tubular epithelial cell injury.
Zhou TB; Ou C; Rong L; Drummen GP
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):243-9. PubMed ID: 25031298
[TBL] [Abstract][Full Text] [Related]
13. [The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients].
Fedor R; Kovács DÁ; Lőcsey L; Fagyas M; Asztalos L; Tóth A
Orv Hetil; 2016 Jun; 157(24):938-45. PubMed ID: 27263433
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
15. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
17. The renin angiotensin system blockade in kidney transplantation: pros and cons.
Cruzado JM; Rico J; Grinyó JM
Transpl Int; 2008 Apr; 21(4):304-13. PubMed ID: 18266774
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
19. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
20. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
Slowinski T; Diehr P; Kleemann P; Fritsche L; Renders L; Budde K; Hauser IA; Neumayer HH; Hocher B
Nephrol Dial Transplant; 2004 Nov; 19(11):2846-51. PubMed ID: 15353577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
